BACKGROUND: Recently, the deleterious metabolic effects of visceral fat [visceral adipose tissue (VAT)] deposition were challenged, and liver fat emerged as having a key independent role in the modulation of cardiometabolic risk factors. OBJECTIVE: We explored the relation between liver fat content and VAT in 3 ethnic groups and evaluated whether the ethnic differences in the distributions of lipoprotein concentrations and sizes were associated with the hepatic fat fraction (HFF), VAT, or both. DESIGN: In a multiethnic group of 33 white, 33 African American, and 33 Hispanic obese adolescents with normal glucose tolerance, we measured VAT and HFF by using magnetic resonance imaging. Fasting lipoprotein particle number and size were measured by using nuclear magnetic resonance spectroscopy. To assess the association between VAT and HFF, we categorized VAT into tertiles. RESULTS: In each ethnic group, HFF values increased between successive tertiles of VAT. After multivariate adjustment and in comparison with the 2 other groups, African Americans showed lower triglyceride (P = 0.001) and higher HDL (P = 0.03) concentrations, lower concentrations of total (P = 0.007), large (P = 0.005), and medium (P lt 0.0001) VLDL, but higher concentrations of large HDL particles (P = 0.01) and larger HDL (P = 0.005). In multivariate linear models, independent of ethnicity, VAT was a significant predictor for large HDL (P = 0.003) and total small LDL (P = 0.001) concentrations, whereas HFF significantly predicted large VLDL (P = 0.03) concentrations. CONCLUSION: Liver fat accretion, independent of VAT, may play a role in the ethnic differences seen in large VLDL particles. This trial was registered at clinicaltrials.gov as NCT00536250.
BACKGROUND: Recently, the deleterious metabolic effects of visceral fat [visceral adipose tissue (VAT)] deposition were challenged, and liver fat emerged as having a key independent role in the modulation of cardiometabolic risk factors. OBJECTIVE: We explored the relation between liver fat content and VAT in 3 ethnic groups and evaluated whether the ethnic differences in the distributions of lipoprotein concentrations and sizes were associated with the hepatic fat fraction (HFF), VAT, or both. DESIGN: In a multiethnic group of 33 white, 33 African American, and 33 Hispanic obese adolescents with normal glucose tolerance, we measured VAT and HFF by using magnetic resonance imaging. Fasting lipoprotein particle number and size were measured by using nuclear magnetic resonance spectroscopy. To assess the association between VAT and HFF, we categorized VAT into tertiles. RESULTS: In each ethnic group, HFF values increased between successive tertiles of VAT. After multivariate adjustment and in comparison with the 2 other groups, African Americans showed lower triglyceride (P = 0.001) and higher HDL (P = 0.03) concentrations, lower concentrations of total (P = 0.007), large (P = 0.005), and medium (P lt 0.0001) VLDL, but higher concentrations of large HDL particles (P = 0.01) and larger HDL (P = 0.005). In multivariate linear models, independent of ethnicity, VAT was a significant predictor for large HDL (P = 0.003) and total small LDL (P = 0.001) concentrations, whereas HFF significantly predicted large VLDL (P = 0.03) concentrations. CONCLUSION: Liver fat accretion, independent of VAT, may play a role in the ethnic differences seen in large VLDL particles. This trial was registered at clinicaltrials.gov as NCT00536250.
Authors: Iva Miljkovic-Gacic; Clareann H Bunker; Robert E Ferrell; Candace M Kammerer; Rhobert W Evans; Alan L Patrick; Lewis H Kuller Journal: Metabolism Date: 2006-01 Impact factor: 8.694
Authors: Mark Fishbein; Fernando Castro; Sailaja Cheruku; Shaily Jain; Brian Webb; Theodore Gleason; W Ross Stevens Journal: J Clin Gastroenterol Date: 2005-08 Impact factor: 3.062
Authors: David S Freedman; Barbara A Bowman; James D Otvos; Sathanur R Srinivasan; Gerald S Berenson Journal: Am J Clin Nutr Date: 2002-05 Impact factor: 7.045
Authors: Catherine W Yeckel; Ram Weiss; James Dziura; Sara E Taksali; Sylvie Dufour; Tania S Burgert; William V Tamborlane; Sonia Caprio Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: Thanh-Binh Nguyen-Duy; Milton Z Nichaman; Timothy S Church; Steven N Blair; Robert Ross Journal: Am J Physiol Endocrinol Metab Date: 2003-01-28 Impact factor: 4.310
Authors: Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio Journal: N Engl J Med Date: 2004-06-03 Impact factor: 91.245
Authors: Peter M Wolfgram; Ellen L Connor; Jennifer L Rehm; Jens C Eickhoff; Scott B Reeder; David B Allen Journal: Obesity (Silver Spring) Date: 2013-09-17 Impact factor: 5.002
Authors: Sheela N Magge; Divya Prasad; Dorit Koren; Paul R Gallagher; Emile R Mohler; Nicolas Stettler; Lorraine E Levitt Katz; Daniel J Rader Journal: J Pediatr Date: 2012-05-22 Impact factor: 4.406
Authors: Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir Journal: Mayo Clin Proc Date: 2014-03-07 Impact factor: 7.616
Authors: Peter M Wolfgram; Ellen L Connor; Jennifer L Rehm; Jens C Eickhoff; Wei Zha; Scott B Reeder; David B Allen Journal: Horm Res Paediatr Date: 2015-09-10 Impact factor: 2.852
Authors: Catherine L Davis; Norman K Pollock; Jennifer L Waller; Jerry D Allison; B Adam Dennis; Reda Bassali; Agustín Meléndez; Colleen A Boyle; Barbara A Gower Journal: JAMA Date: 2012-09-19 Impact factor: 56.272